10h
Esperion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
FY25 Total Revenue Grew 21% Y/Y to $403.1 Million; FY25 U.S. Net Product Revenue Grew 38% Y/Y to $159.6 Million –– Q4 2025 U.S. Net Product ...
Known for a career defined by intellectual rigour and an investor's discipline, Anthony Gonsalves offers a perspective on money that cuts through the noise of market cycles and media speculation. His ...
- FY25 Total Revenue Grew 21% Y/Y to $403.1 Million; FY25 U.S. Net Product Revenue Grew 38% Y/Y to $159.6 Million - - Q4 2025 U.S. Net Product Revenue Grew ~38% Y/Y to $43.7 Million; Q4 2025 Total ...
NOIDA: A QR code printed on the Central Board of Secondary Education (CBSE) Class 12 mathematics question paper triggered speculation after several st.
Ontario Teachers’ Pension Plan Board (Ontario Teachers’) today announced a one-year total-fund net return of 6.7% for the year ended December 31, 20251, compared to a 9.
Vertex Pharmaceuticals Incorporated today announced positive data from a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results